SISRAM MEDICAL LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.54 HKD | +7.93% |
|
+13.46% | -32.70% |
| Mar. 21 | Sisram Medical’s Profit Down in Fiscal 2023 | MT |
| Mar. 20 | Sisram Medical Ltd Announces Ordinary Final Cash Dividend for the Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 234.4 | 188.8 | 567.5 | 533.7 | 211.8 | 211.8 | - |
| Enterprise Value (EV) 1 | 234.4 | 188.8 | 567.5 | 533.7 | 315.5 | 211.8 | 211.8 |
| P/E ratio | 11.3 x | 14.1 x | 17.6 x | 13.3 x | - | - | - |
| Yield | - | - | - | - | 3% | 4.42% | 6.63% |
| Capitalization / Revenue | - | - | - | 1.51 x | 0.88 x | 0.54 x | 0.48 x |
| EV / Revenue | - | - | - | 1.51 x | 0.88 x | 0.54 x | 0.48 x |
| EV / EBITDA | - | - | - | 9.03 x | 5.82 x | 4.11 x | 3.65 x |
| EV / FCF | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - |
| Price to Book | - | - | - | 1.24 x | 0.69 x | 0.44 x | 0.42 x |
| Nbr of stocks (in thousands) | 442,156 | 442,156 | 466,156 | 467,293 | 468,343 | 468,343 | - |
| Reference price 2 | 0.5302 | 0.4269 | 1.217 | 1.142 | 0.4522 | 0.4522 | 0.4522 |
| Announcement Date | 3/18/20 | 3/18/21 | 3/16/22 | 3/21/23 | 3/20/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | - | - | - | 354.5 | 359.3 | 394.5 | 438 |
| EBITDA 1 | - | - | - | 59.14 | 54.23 | 51.5 | 58 |
| EBIT 1 | - | - | - | 46.21 | 39.58 | 45 | 52 |
| Operating Margin | - | - | - | 13.04% | 11.01% | 11.41% | 11.87% |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - |
| Net income 1 | 20.78 | 13.34 | 31.24 | - | 31.5 | 35 | 40.5 |
| Net margin | - | - | - | - | 8.77% | 8.87% | 9.25% |
| EPS | 0.0470 | 0.0302 | 0.0690 | 0.0861 | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - |
| FCF margin | - | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | 0.0202 | 0.0200 | 0.0300 |
| Announcement Date | 3/18/20 | 3/18/21 | 3/16/22 | 3/21/23 | 3/20/24 | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | 9.64% | 7.13% | 7.45% | 8.1% |
| ROA (Net income/ Total Assets) | - | - | - | 7.4% | 5.39% | 5.7% | 6.05% |
| Assets 1 | - | - | - | - | 584.5 | 614 | 669.4 |
| Book Value Per Share 2 | - | - | - | 0.9200 | 0.9700 | 1.020 | 1.080 |
| Cash Flow per Share 2 | - | - | - | - | 0.0900 | 0.0500 | 0.0400 |
| Capex 1 | - | - | - | 4.7 | 8.6 | 10 | 12.5 |
| Capex / Sales | - | - | - | 1.33% | 2.39% | 2.53% | 2.85% |
| Announcement Date | 3/18/20 | 3/18/21 | 3/16/22 | 3/21/23 | 3/20/24 | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.4522
USD
Average target price
0.7795
USD
Spread / Average Target
+72.38%
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -32.70% | 212M | |
| +19.38% | 994M | |
| -35.85% | 74.33M |
- Stock Market
- Equities
- 1696 Stock
- Financials Sisram Medical Ltd
